Occidental Petroleum Faces Investor Skepticism Amid Strategic Overhaul

Wall Street analysts are delivering sharply conflicting assessments of Occidental Petroleum’s prospects, creating uncertainty for investors during a pivotal transformation for the energy company. The central debate revolves around whether the oil and gas producer’s strategic repositioning will ultimately win over market confidence.

Conflicting Analyst Views Create Market Uncertainty

Financial experts are deeply divided on Occidental’s outlook. Wells Fargo initiated coverage with an “Underweight” rating and set a price target of just $42 per share. This pessimistic stance contrasts sharply with more optimistic evaluations from other institutions. JP Morgan raised its price objective to $50, while UBS maintained its $45 target. BMO Capital Markets projected the most bullish outlook with a $51 price target. This wide dispersion in valuations reflects fundamental disagreements about how to assess Occidental’s changing corporate direction.

Strategic Shift Through Major Asset Divestiture

The company is undergoing substantial changes under CEO Vicki Hollub’s leadership. Occidental recently completed the sale of its chemical subsidiary OxyChem to Berkshire Hathaway in a transaction valued at $9.7 billion, signaling a significant strategic departure. Company leadership has announced they are “done with major deals” and will now concentrate exclusively on core oil and gas operations. Approximately $6.5 billion from the sale proceeds will be allocated to debt reduction, with the ambitious goal of bringing total debt below $15 billion.

Should investors sell immediately? Or is it worth buying Occidental Petroleum?

However, this strategic move has generated controversy among market observers. Some analysts question whether the divestiture occurred at an inopportune time and potentially undervalued the asset. Concerns are mounting that this decision might negatively impact future free cash flow generation capabilities.

Critical Quarterly Report Approaches

All attention now turns to November 10, when Occidental will release its third-quarter 2025 financial results. Expectations are notably subdued, with Zacks Research forecasting earnings per share of just $0.48—representing a dramatic 52% decline compared to the same quarter last year.

The company’s shares currently trade closer to their 52-week low than their high, indicating persistent market skepticism about the ongoing transformation. With the stock down more than 11% over the past month and over 27% year-to-date, Occidental faces a crucial test of its revised business strategy. The upcoming quarterly report may determine whether the streamlined oil and gas producer can convince doubters of its renewed focus and financial discipline.